Emergency department response to the deliberate release of biological agents

Emergency Medicine Journal

Volumn 21, Issue 1, 2004, Pages 5-8

  Ollerton, J E ^a  

^a LIVERPOOL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BOTULINUM TOXIN; RICIN; STAPHYLOCOCCUS ENTEROTOXIN B; TOXIN; VACCINE;

ANTHRAX; ARENAVIRUS; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; BRUCELLA; BURKHOLDERIA PSEUDOMALLEI; CLOSTRIDIUM BOTULINUM; COMMUNICABLE DISEASE; COXIELLA BURNETII; CRYPTOSPORIDIUM PARVUM; DISEASE CONTROL; DISEASE TRANSMISSION; EMERGENCY WARD; ESCHERICHIA COLI; FILOVIRUS; FRANCISELLA TULARENSIS; HEALTH HAZARD; HUMAN; INFECTION; NONHUMAN; PLAGUE; PRIORITY JOURNAL; PROPHYLAXIS; PROTECTIVE CLOTHING; PUBLIC HEALTH; REVIEW; RICKETTSIA PROWAZEKII; SAFETY; SALMONELLA; SMALLPOX; SMALLPOX VIRUS; TERRORISM; THREAT; TULAREMIA; VACCINATION; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS HEMORRHAGIC FEVER; VIRUS INFECTION; WAR; WESTERN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; YERSINIA PESTIS;

BIOTERRORISM; DECONTAMINATION; EMERGENCY SERVICE, HOSPITAL; HUMANS; PUBLIC HEALTH PRACTICE;

EID: 0842308054     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2003.005439     Document Type: Review

References (12)

1. Lederberg J. Germs as weapons: A grim history. A lecture by Dr. J Lederberg, 27 Oct 1999 at Weill Medical of College of Cornell, Manhattan. Summarized by Felicia Narvaez 4 Nov 1999 (http://www.news.cornell.edu/chronicle/99/11.4.99/bio_warfare.html).
2. Biological Weapons Convention 1972. Summary available at http://www.fas.org/nuke/control/bwc/text/bwc.htm.
3. Centers for Disease Control and Prevention. Biological and chemical terrorism: Strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup 2000. MMWR Morb Mortal Wkly Rep 2000;49:1-14.
4. Rotz LD, Khan AS, Lillibridge SR, et al. Report summary. Public health assessment of potential biological terrorism agents. Emerg Infect Dis 2002;8:1-11, (http://www.cdc.gov/ncidod/EID/vol8no2/01/0164.htm).
5. Jackson RJ, Ramsay AJ, Christensen CD, et al. Expression of mouse interleukin-4 by a recombinant Ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to Mousepox. J Virol 2001;75:1205-10.
6. Mobile Decontamination Facilities and Personal Protective Equipment. Department of Health letter to Chief Executives of NHS Trusts dated 22 Oct 2002 (http://www.doh.gov.uk/publications/index.html).
7. The Interdepartmental Working Group on Tuberculosis. The Prevention and Control of Tuberculosis in the United Kingdom. London: Department of Health, the Scottish Office, the Welsh Office, September 1998.
8. PHLS. Initial investigation and management of outbreaks and incidents of unusual illness. A guide for hospital clinicians. PHLS and Chemical Incident Response Service, 2002. (http://www.phls.org.uk).
9. Department of Health. Pre-hospital chemical and biological incident response. A briefing document by the Department of Health dated 23 Oct (http://www.doh.gov.uk/epcu/cbr/cbrpdf/prehosp.pdf).
10. Department of Health. Hospital chemical incident response-practical advice. From the Department of Health dated 28 Sep 2001 (http://www.doh.gov.uk/epcu/cbrpdf/hospcir.pdf).
11. Department of Health. The decontamination of people exposed to chemical, biological, radiological or nuclear (CBRN) substances or material: Strategic National Guideline. The Home Office Feb 2003. (http://www.doh.gov.uk/epcu/cbr/cbrpdf/cbrn2003.pdf).
12. Department of Health and NHS Executive. Deliberate Release of Biological and Chemical Agents - Guidance to Help Plan the Health Service Response. London: Department of Health, March 2000.